Try the Demo today!
| SEC Filing | Insider | Company | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Return |
|---|---|---|---|---|---|---|---|---|---|
| 26-May-22 6:00 PM View:  | Sendrow Jerrold Director | Virpax Pharmaceuticals, Inc. (VRPX) | 24-May-22 | Private Purchase | 4,500 | $1.29 | $5,805.00 | 100% 4.51K to 9.01K | |
| 20-May-22 6:15 PM View: | MacK Anthony P. Chief Executive Officer Director | Virpax Pharmaceuticals, Inc. (VRPX) | 18-May-22 | Private Purchase | 75,750 | $1.34 | $101,505.00 | 3% 2.91M to 2.98M | |
| 20-May-22 6:12 PM View: | Floyd Eric Director | Virpax Pharmaceuticals, Inc. (VRPX) | 18-May-22 | Private Purchase | 4,479 | $1.36 | $6,107.12 | 127% 3.54K to 8.02K | |
| 24-Nov-21 4:30 PM View: | Sendrow Jerrold Director | Virpax Pharmaceuticals, Inc. (VRPX) | 22-Nov-21 | Market Purchase | 3,900 | $3.92 | $15,307.50 | 644% 0.61K to 4.51K | 9% |
| 22-Nov-21 6:00 PM View: | MacK Anthony P. Chief Executive Officer Director 10% Owner | Virpax Pharmaceuticals, Inc. (VRPX) | 18-Nov-21 | Market Purchase | 25,125 | $3.99 | $100,249.00 | < 1% 2.88M to 2.91M | 4% |
| 19-Feb-21 6:22 PM View: | Jacob Gary S Director | Virpax Pharmaceuticals, Inc. (VRPX) | 17-Feb-21 | Purchase | 3,500 | $6.79 | $23,761.50 | 100% 0 to 3.5K | |
| 01-Mar-21 6:00 PM View: | Jambulingam Thani Director | Virpax Pharmaceuticals, Inc. (VRPX) | 17-Feb-21 | Purchase | 100 | $7.16 | $716.00 | 100% 0 to 100 |
